Implementation of phase 0 trials

被引:0
|
作者
Schellens, J. H. M. [1 ]
机构
[1] Netherlands Canc Inst, Amsterdam, Netherlands
来源
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词
D O I
10.1016/S1359-6349(08)71954-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
  • [21] Phase 0 Clinical Trials: An Answer to Drug Development Stagnation?
    LoRusso, Patricia M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) : 2586 - 2588
  • [22] Implementation of adaptive methods in early-phase clinical trials
    Petroni, Gina R.
    Wages, Nolan A.
    Paux, Gautier
    Dubois, Frederic
    STATISTICS IN MEDICINE, 2017, 36 (02) : 215 - 224
  • [23] Compressing drug development timelines in oncology using phase '0' trials
    Kummar, Shivaani
    Kinders, Robert
    Rubinstein, Larry
    Parchment, Ralph E.
    Murgo, Anthony J.
    Collins, Jerry
    Pickeral, Oxana
    Low, Jennifer
    Steinberg, Seth M.
    Gutierrez, Martin
    Yang, Sherry
    Helman, Lee
    Wiltrout, Robert
    Tomaszewski, Joseph E.
    Doroshow, James H.
    NATURE REVIEWS CANCER, 2007, 7 (02) : 131 - 139
  • [24] Target validation using Phase 0 clinical trials Promises and pitfalls
    Angelo, Laura S.
    Kurzrock, Razelle
    CANCER BIOLOGY & THERAPY, 2009, 8 (21) : 2010 - 2012
  • [25] Phase 0 (zero) clinical trials: More than zero benefit?
    Schellens, Jan H. M.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) : 728 - 729
  • [26] Compressing drug development timelines in oncology using phase '0' trials
    Shivaani Kummar
    Robert Kinders
    Larry Rubinstein
    Ralph E. Parchment
    Anthony J. Murgo
    Jerry Collins
    Oxana Pickeral
    Jennifer Low
    Seth M. Steinberg
    Martin Gutierrez
    Sherry Yang
    Lee Helman
    Robert Wiltrout
    Joseph E. Tomaszewski
    James H. Doroshow
    Nature Reviews Cancer, 2007, 7 : 131 - 139
  • [27] Phase 0 clinical trials: towards a more complete ethics critique
    Hill, T. Patrick
    ECANCERMEDICALSCIENCE, 2012, 6
  • [28] The application of human phase 0 microdosing trials: A systematic review and perspectives
    Svendsen, Pernille
    El-Galaly, Tarec C.
    Dybkaer, Karen
    Bogsted, Martin
    Laursen, Maria B.
    Schmitz, Alexander
    Jensen, Paw
    Johnsen, Hans E.
    LEUKEMIA & LYMPHOMA, 2016, 57 (06) : 1281 - 1290
  • [29] Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Chris H. Takimoto
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 703 - 709
  • [30] Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient
    Doroshow, James H.
    Parchment, Ralph E.
    CLINICAL CANCER RESEARCH, 2008, 14 (12) : 3658 - 3663